Chatbots Battle COVID-19 Vaccine Hesitancy

This article originally appeared on the Johns Hopkins University website. Below is a brief excerpt.

As COVID-19 vaccines were still racing through clinical trials, a team at Johns Hopkins University developed VIRA, the Vaccine Information Resource Assistant. The chatbot debuted first as a webpage in July 2021, and later, with the marketing and technical support of Meta (previously Facebook), as a WhatsApp version this past January. The app is currently available in the U.S. in both English and Spanish, and the team is building international models.

Responding immediately to user questions, VIRA offers concise, plainspoken, expert-vetted answers to questions about COVID-19 vaccines, linking to trusted sources for further information.

Learn how the VIRA chatbot has been helping combat vaccine hesitancy.

Leave a Reply

Your email address will not be published.

You May Also Like

📣 Lessons from Moldova on the Use of Pharmacists to Increase Demand for COVID-19 Vaccinations

When the COVID-19 vaccines first launched in Moldova, vaccine confidence across the country was low, particularly among target populations. To combat this, Moldova launched a national campaign using pharmacists to increase awareness, confidence, and coverage of the vaccines. Linked recently sat down with Oxana Constantinova, Doctor Epidemiologist, Center for Public Health, Moldova, to understand the … Continued

Three Insights to Help Overcome COVID-19 Vaccine Hesitancy

Research conducted in eight countries – Liberia, Côte d’Ivoire, Cameroon, Senegal, Mali, Burkina Faso, Philippines, and Nigeria – is beginning to understand and target demand-side barriers to improve acceptance and uptake of the COVID-19 vaccine. This blog provides three cross-cutting behavioral insights that suggest opportunities to encourage COVID vaccine uptake in low-resource settings, despite persistent … Continued